Abstract
Nephrotic syndrome is comprised of massive proteinuria in association with hypoalbuminemia, hyperlipidemia, and edema. Thromboembolism is an important source of morbidity and mortality in nephrotic syndrome and virtually any location may be affected. This review focuses on the epidemiology, pathophysiology, clinical features, and diagnosis of thromboembolism in pediatric nephrotic syndrome.
Keywords: Thromboembolism, thrombus, nephrotic syndrome, pediatrics.
Current Pediatric Reviews
Title:Thrombosis and Nephrotic Syndrome in Children
Volume: 9 Issue: 3
Author(s): T. Matthew Eison, Oulimata Kane and Noel Delos Santos
Affiliation:
Keywords: Thromboembolism, thrombus, nephrotic syndrome, pediatrics.
Abstract: Nephrotic syndrome is comprised of massive proteinuria in association with hypoalbuminemia, hyperlipidemia, and edema. Thromboembolism is an important source of morbidity and mortality in nephrotic syndrome and virtually any location may be affected. This review focuses on the epidemiology, pathophysiology, clinical features, and diagnosis of thromboembolism in pediatric nephrotic syndrome.
Export Options
About this article
Cite this article as:
Eison T. Matthew, Kane Oulimata and Santos Noel Delos, Thrombosis and Nephrotic Syndrome in Children, Current Pediatric Reviews 2013; 9 (3) . https://dx.doi.org/10.2174/1573396311309030002
DOI https://dx.doi.org/10.2174/1573396311309030002 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Sonic Hedgehog Signaling Activation Promotes Cardioprotective Strategies
Current Signal Transduction Therapy Adrenomedullin Function in Vascular Endothelial Cells: Insights from Genetic Mouse Models
Current Hypertension Reviews The Effects of Mesenchymal Stem Cells in Craniofacial Tissue Engineering
Current Stem Cell Research & Therapy Kidney in Diabetes: from Organ Damage Target to Therapeutic Target
Current Drug Metabolism Glucocorticoids and the Cardiovascular System: State of the Art
Current Pharmaceutical Design Shutting Down the Furnace: Preferential Killing of Cancer Cells with Mitochondrial-Targeting Molecules
Current Medicinal Chemistry Voltage-Gated Sodium Channels as Therapeutic Targets for Treatment of Painful Diabetic Neuropathy
Mini-Reviews in Medicinal Chemistry Advances in the Molecular Genetics of Non-syndromic Syndactyly
Current Genomics Pharmacological Therapy in Children with Atrial Fibrillation and Atrial Flutter
Current Pharmaceutical Design MicroRNAs and the Heart: Small Things Do Matter
Current Topics in Medicinal Chemistry Thrombotic Thrombocytopenic Purpura, from the Perspectives of a Pediatrician
Current Pediatric Reviews Exploring Sterol and Lipid Biology in the Functional Genomic Era
Current Pharmaceutical Biotechnology Dealing with the Substance Abuse Epidemic and Infective Endocarditis:Clinical, Immunologic and Pathogenetic Aspects
Current Vascular Pharmacology The Adult Patient with Eisenmenger Syndrome: A Medical Update after Dana Point Part III: Specific Management and Surgical Aspects
Current Cardiology Reviews Withdrawal Notice: Emerging Biomarkers and Contributing Factors of Prostate Cancer
Current Cancer Therapy Reviews The Coronary Circulation in Cyanotic Congenital Heart Disease
Current Cardiology Reviews Reproductive Effects of Low-to-Moderate Medical Radiation Exposure
Current Medicinal Chemistry Varicella-Zoster Virus Infections During Pregnancy: Epidemiology, Clinical Symptoms, Diagnosis, Prevention and Therapy
Current Pediatric Reviews Targeted Delivery for Neurodegenerative Disorders Using Gene Therapy Vectors: Gene Next Therapeutic Goals
Current Gene Therapy Harnessing the Potential of Long Non-coding RNAs to Manage Metabolic Diseases
Current Pharmaceutical Design